Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, DB, Plcb Controlled, Multicentre, Multinat. Phase II/III FU Study to Assess Longterm Efficacy and Safety of 3 Different Dose Regimens of Oralgen® GrassPollen in Patients With Grass Pollen Related Allergic Rhinoconjunctivitis

NCT00824447 is registered in ClinicalTrials.gov with Artu Biologicals as lead sponsor.

NCT NCT00824447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00824447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, DB, Plcb Controlled, Multicentre, Multinat. Phase II/III FU Study to Assess Longterm Efficacy and Safety of 3 Different Dose Regimens of Oralgen® GrassPollen in Patients With Grass Pollen Related Allergic Rhinoconjunctivitis
Lead sponsor
Artu Biologicals
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2007
Completion date
January 31, 2009
Enrollment
356 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinoconjunctivitis